abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Article

25 Mar 2020

Author:
Investor Alliance for Human Rights

[Letter] Investor Statement Calling on Companies to Improve Performance on the Corporate Human Rights Benchmark

See all tags

The undersigned 176 investors representing over US$4.5 trillion in assets under management are writing to express our concern regarding the company’s ranking in the 2019 Corporate Human Rights Benchmark (CHRB)...

[B]ased on the latest CHRB ranking, which assessed 200 companies in high-risk sectors against five human rights due diligence indicators, your company has scored zero on all five indicators. We are concerned that a lack of public communication on human rights suggests the Company has not assessed associated risks or determined how best to mitigate them.

We are therefore calling on the Company to demonstrate respect for human rights by publicly disclosing the following by June 2020:

  1. Your processes to identify and assess adverse human rights risks and impacts in your operations and throughout your business relationships, including throughout your supply chain;

  2. Your processes for prioritizing your salient human rights issues, meaning the most severe impacts on people connected to your business;

  3. Your salient human rights impacts, including impacts in the supply chain,

  4. Your actions to prevent, mitigate, and remediate adverse impacts in relation to your salient human

    rights issues and how these actions apply across your value chain; and

  5. Your approach to tracking the actions taken, how those actions are evaluated and revised for effectiveness, and the effectiveness of your approaches in addressing those adverse impacts.

Timeline